Prospective observational study aimed at analyzing the incidence, clinical characteristics and outcomes of COVID-19 in LT in Spain.
Coronavirus Disease 2019 (COVID-19) is a novel viral disease caused by the SARS-Cov-2
infection with a particular predominance of upper and lower respiratory tract symptoms. First
diagnosed in China in late 2019, the virus has progressed to a state of pandemia, involving
Spain with a important outbreak.
While the outcomes of viral infections in solid organ transplant (SOT) recipients tend to be
worse than those from the general population due to chronic immunosuppression, there is
little information on the incidence and outcomes of COVID-19 in liver transplant (LT)
recipients. LT recipients are usually under less immunosuppression than other SOT and the
clinical expression and outcomes of COVID-19 may be different to the reported outcomes in
other SOT.
The Spanish Society of Liver Transplantation, which includes 25 LT programs, has promoted a
nationwide registry for LT with COVID-19 to help ascertain the incidence and outcomes and
help evidence-based management .
Other: Observational only
Observational Study
Inclusion Criteria:
- Liver Transplant recipient
- Confirmed (PCR positive) SARS-Cov-2 infection
- Informed Consent
SETH-affiliated Liver Transplant Programs in Spain
Barcelona, Spain
Jordi Colmenero, Principal Investigator
Sociedad Española de Trasplante Hepático